Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 11:35:04 2024-04-19 am EDT			5-day change	1st Jan Change
198.2 ^USD	-0.69%		-4.08%	+3.00%

Apr. 16	Veeva Systems Insider Sold Shares Worth $746,297, According to a Recent SEC Filing	MT
Apr. 02	Tech Down on Flight From Risk -- Tech Roundup	DJ

Veeva Systems Inc. Reports Earnings Results for the First Quarter Ended April 30, 2021

May 27, 2021 at 04:05 pm EDT

Veeva Systems Inc. announced earnings results for the first quarter ended April 30, 2021. For the first quarter, the company announced total revenue was USD 433.573 million compared to USD 337.106 million a year ago. Operating income was USD 128.446 million compared to USD 87.565 million a year ago. Net income was USD 115.567 million compared to USD 86.570 million a year ago.

Latest news about Veeva Systems Inc.

Veeva Systems Insider Sold Shares Worth $746,297, According to a Recent SEC Filing	Apr. 16	MT
Tech Down on Flight From Risk -- Tech Roundup	Apr. 02	DJ
News Highlights : Top Company News of the Day - Tuesday at 5 PM ET	Apr. 02	DJ
Sector Update: Tech Stocks Slump Late Afternoon	Apr. 02	MT
Sector Update: Tech	Apr. 02	MT
News Highlights : Top Company News of the Day - Tuesday at 3 PM ET	Apr. 02	DJ
News Highlights : Top Company News of the Day - Tuesday at 1 PM ET	Apr. 02	DJ
Veeva Systems Shares Fall After Chief Financial Officer Brent Bowman Steps Down	Apr. 02	MT
Sector Update: Tech Stocks Decline Pre-Bell Tuesday	Apr. 02	MT
Veeva Systems Chief Financial Officer Steps Down	Apr. 02	MT
Veeva Systems Inc. Announces CFO Changes	Apr. 01	CI
Veeva Systems Inc. Announces Executive Changes	Apr. 01	CI
Veeva Systems Inc. Reiterates Earnings Guidance for the First Quarter Ending April 30, 2024 and for the Fiscal Year Ending January 31, 2025	Apr. 01	CI
Add a little SaaS to your life	Mar. 14
Not a care in the world	Mar. 13
JPMorgan Raises Veeva Systems Price Target to $222 From $183, Maintains Neutral Rating	Mar. 13	MT
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK	Mar. 13
Another disappointment	Mar. 12
Morgan Stanley Raises Price Target on Veeva Systems to $210 From $160 Amid Multiple Expansion in Large-Capitalization Software; Underweight Kept	Mar. 12	MT
ANALYST RECOMMENDATIONS : Coinbase, Dollar General, Target, Veeva, Capita...	Mar. 12
Transcript : Veeva Systems Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-06-2024 09:30 AM	Mar. 06
KeyBanc Raises Price Target on Veeva Systems to $250 From $232, Keeps Overweight Rating	Mar. 05	MT
Jefferies Raises Price Target on Veeva Systems to $270 From $225, Maintains Buy Rating	Mar. 04	MT
Veeva Systems Cites 'More Optimism' Among Large Pharma Customers Amid Macro Hurdles, UBS Says	Mar. 01	MT
Truist Securities Raises Veeva Systems' Price Target to $203 From $187, Keeps Hold Rating	Mar. 01	MT

Chart Veeva Systems Inc.

Duration

Period

More charts

Company Profile

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-06 - North America Commercial Summit

More about the company

Income Statement Evolution

More financial data

Ratings for Veeva Systems Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

199.5 USD

Average target price

241.8 USD

Spread / Average Target

+21.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+2.98%	32.2B
PRO MEDICUS LIMITED	+7.44%	6.87B
SECTRA AB	+15.39%	3.66B
EVOLENT HEALTH, INC.	-11.11%	3.37B
OMNICELL, INC.	-26.39%	1.25B
LUNIT INC.	-38.10%	1.06B
SIMULATIONS PLUS, INC.	+0.40%	888M
B-SOFT CO.,LTD.	-41.37%	819M
VERADIGM INC.	-27.45%	813M
SURGICAL SCIENCE SWEDEN AB	-20.60%	691M

Medical Software & Technology Services